Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Prostate Cancer Urine Test Predicts Biopsy Test Results
Link ID 23077
Title Prostate Cancer Urine Test Predicts Biopsy Test Results
Url http://www.medscape.com/viewarticle/718081?src=rss
Description A urine test may be able to help predict which men with elevated PSA levels yet no positive biopsy result will develop prostate cancer. Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Mar 9, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Treatment With VEGF Inhibitors May Cause Renal Thrombotic Microangiopathy
  VEGF inhibitors, such as bevacizumab, may cause glomerular disease that is characteristic of thrombotic microangiopathy. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. ESAs Should Continue to be Used for Anemia in Cancer Patients, Says FDA Advisory Committee
  Erythropoiesis-stimulating agents should continue to have an oncology indication, even though questions about their safety remain. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. Improved Breast Cancer Survival Following Introduction of an Organized Mammography Screening Program
  This study investigated whether mammography screening is associated with optimized treatment and improved survival through multidisciplinary medical care. Breast Cancer Research
Category:   Articles > Hematology-Oncology


4. Vitamin D May Not Decrease Risk for Prostate Cancer
  In a large prospective study, higher circulating serum concentrations of 25-hydroxyvitamin D were associated with an increased risk for aggressive prostate cancer. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. A Phase II Randomized Crossover Study of Liposomal Doxorubicin Versus Weekly Docetaxel in the First-
  Metastatic breast cancer first-line treatments with varying dosing frequencies are compared for efficacy and toxicity. Is one regimen superior? Clinical Breast Cancer
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS